Status:
UNKNOWN
Clinical Study of Serum Fetuin A Level, Insulin Resistance and Hepatic Fat Content in Dialysis Patients
Lead Sponsor:
Far Eastern Memorial Hospital
Collaborating Sponsors:
National Taiwan University Hospital
Conditions:
Fatty Liver
Eligibility:
All Genders
20-80 years
Brief Summary
Background Fetuin A, synthesized in hepatocyte, is a circulatory inhibitor of precipitation of calcium and phosphate and links to cardiovascular calcification and mortality in dialysis patients; besid...
Detailed Description
Background: Fetuin A is a protein secreted by hepatocytes that inhibits insulin receptor tyrosine kinase of adipose and muscle cells (1, 2). Recently, its inhibitory potency on calcium phosphate prec...
Eligibility Criteria
Inclusion
- ESRD patients undergoing maintenance HD or PD for more than 6 months
- Age\>20
Exclusion
- Recent hospitalization duet active medical or psychiatric problems
- Active malignancy
- Patient refusal
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2014
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01457625
Start Date
January 1 2011
End Date
January 1 2014
Last Update
October 24 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Eastern Memorial Hospital
New Taipei City, Taiwan
2
Far eastern memorial hospital
New Taipei City, Taiwan